Accelerate Diagnostics, Inc. (LON:0H8E)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.0126
+0.0001 (0.80%)
At close: May 22, 2025

Accelerate Diagnostics Statistics

Total Valuation

LON:0H8E has a market cap or net worth of GBP 103,987. The enterprise value is 37.17 million.

Market Cap 103,987
Enterprise Value 37.17M

Important Dates

The next estimated earnings date is Thursday, September 18, 2025.

Earnings Date Sep 18, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 25.19M
Shares Outstanding n/a
Shares Change (YoY) +86.76%
Shares Change (QoQ) +1.17%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 13.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.01
PB Ratio -0.00
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.93
EV / Sales 4.31
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.88

Financial Position

The company has a current ratio of 0.71

Current Ratio 0.71
Quick Ratio 0.59
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.70
Interest Coverage -2.69

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -73.66%
Return on Invested Capital (ROIC) -147.78%
Return on Capital Employed (ROCE) 1,334.97%
Revenue Per Employee 87,327
Profits Per Employee -373,593
Employee Count 107
Asset Turnover 0.39
Inventory Turnover 2.92

Taxes

Income Tax -52,719
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.76% in the last 52 weeks. The beta is -0.13, so LON:0H8E's price volatility has been lower than the market average.

Beta (5Y) -0.13
52-Week Price Change -98.76%
50-Day Moving Average 1.02
200-Day Moving Average 5.92
Relative Strength Index (RSI) 20.89
Average Volume (20 Days) 36,644

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.21

Income Statement

In the last 12 months, LON:0H8E had revenue of GBP 9.34 million and -39.97 million in losses. Loss per share was -1.72.

Revenue 9.34M
Gross Profit 2.16M
Operating Income -28.20M
Pretax Income -40.03M
Net Income -39.97M
EBITDA -25.47M
EBIT -28.20M
Loss Per Share -1.72
Full Income Statement

Balance Sheet

The company has 13.02 million in cash and 53.18 million in debt, giving a net cash position of -40.16 million.

Cash & Cash Equivalents 13.02M
Total Debt 53.18M
Net Cash -40.16M
Net Cash Per Share n/a
Equity (Book Value) -44.76M
Book Value Per Share -1.78
Working Capital -7.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.33 million and capital expenditures -406,574, giving a free cash flow of -19.73 million.

Operating Cash Flow -19.33M
Capital Expenditures -406,574
Free Cash Flow -19.73M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 23.12%
Operating Margin -301.85%
Pretax Margin -428.37%
Profit Margin n/a
EBITDA Margin -272.60%
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LON:0H8E does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -86.76%
Shareholder Yield n/a
Earnings Yield -38,441.83%
FCF Yield -18,975.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 12, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date Jul 12, 2023
Split Type Reverse
Split Ratio 0.1

Scores

LON:0H8E has an Altman Z-Score of -39.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -39.07
Piotroski F-Score 3